|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01069 CN HEALTH TECH
Nominal 
0.400 -0.005 (-1.235%) | 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Turnover | 34,393 | 10.546% | 90,215 | 47,606 | 58,717 | 6,756 |
| Cost of Sales | (30,256) | 6.780% | (82,002) | (45,709) | (47,207) | -- |
| Gross Profit | 4,137 | 48.974% | 8,213 | 1,897 | 11,510 | -- |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | 202,024 | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,256 | 4.244% | 23,026 | 200,020 | (9,374) | (20,383) | |
| Taxation | (4) | -93.750% | (315) | (7) | (1,426) | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | 1,483 | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 5,252 | 5.504% | 22,711 | 200,013 | (10,800) | (18,900) | |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/06 RMB(K¥) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,795 | 34.457% | 3,500 | 3,225 | 11,671 | 21,218 |
| Depreciation & Amortisation | 1,696 | -40.071% | 4,753 | 5,137 | 2,520 | 1,715 |
| Directors' Emoluments | 371 | -11.876% | 792 | 1,319 | 2,259 | 3,606 |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Qualified | Qualified | Disclaimer |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2025/06 | 2024/06 | 2023/06 | 2022/06 | |
| EPS (cts) | 5.250 | -16.667% | 27.500 | 297.900 | -98.000 | -171.400 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.420 | 0.430 | 0.213 | (0.004) |
| NBV per share ($) | 0.553 | -- | 0.544 | 0.181 | (28.728382) | (27.814666) |
| Remarks: | Real time quote last updated: 05/03/2026 10:26 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,252 |
| %Change | 5.504% |
| EPS / (LPS) | RMB 0.053 |
| NBV Per Share (¥) | RMB 0.553 |